• Allison L Miller, Gary P Sims, Yambasu A Brewah, Marlon C Rebelatto, Jennifer Kearley, Ebony Benjamin, Ashley E Keller, Philip Brohawn, Ronald Herbst, Anthony J Coyle, Alison A Humbles, and Roland Kolbeck.
• Departments of Respiratory, Inflammation and Autoimmunity, Gaithersburg, MD, USA.
• J. Infect. Dis. 2012 Apr 15;205(8):1311-20.

AbstractRespiratory syncytial virus (RSV), a common respiratory pathogen in infants and the older population, causes pulmonary inflammation and airway occlusion that leads to impairment of lung function. Here, we have established a role for receptor for advanced glycation end products (RAGE) in RSV infection. RAGE-deficient (ager(-/-)) mice were protected from RSV-induced weight loss and inflammation. This protection correlated with an early increase in type I interferons, later decreases in proinflammatory cytokines, and a reduction in viral load. To assess the contribution of soluble RAGE (sRAGE) to RSV-induced disease, wild-type and ager(-/-) mice were given doses of sRAGE following RSV infection. Of interest, sRAGE treatment prevented RSV-induced weight loss and neutrophilic inflammation to a degree similar to that observed in ager(-/-) mice. Our work further elucidates the roles of RAGE in the pathogenesis of respiratory infections and highlights the opposing roles of membrane and sRAGE in modulating the host response to RSV infection.

17 keywords...

hide…